<info type="SequenceVariant">Large contiguous gene deletions</info> in <info type="DiseaseOrPhenotypicFeature">Sjogren-Larsson syndrome</info>.

<info type="DiseaseOrPhenotypicFeature">Sjogren-Larsson syndrome</info> (<info type="DiseaseOrPhenotypicFeature">SLS</info>) is an <info type="DiseaseOrPhenotypicFeature">autosomal recessive disorder</info> characterized by <info type="DiseaseOrPhenotypicFeature">ichthyosis</info>, <info type="DiseaseOrPhenotypicFeature">mental retardation</info>, <info type="DiseaseOrPhenotypicFeature">spasticity</info> and mutations in the <info type="GeneOrGeneProduct">ALDH3A2</info> gene for <info type="GeneOrGeneProduct">fatty aldehyde dehydrogenase</info>, an <info type="GeneOrGeneProduct">enzyme</info> that catalyzes the oxidation of <info type="ChemicalEntity">fatty aldehyde</info> to <info type="ChemicalEntity">fatty acid</info>. More than 70 <info type="SequenceVariant">mutations</info> have been identified in <info type="DiseaseOrPhenotypicFeature">SLS</info> patients, including <info type="SequenceVariant">small deletions</info> or <info type="SequenceVariant">insertions</info>, <info type="SequenceVariant">missense mutations</info>, <info type="SequenceVariant">splicing defects</info> and <info type="SequenceVariant">complex nucleotide changes</info>. We now describe 2 <info type="DiseaseOrPhenotypicFeature">SLS</info> patients whose <info type="DiseaseOrPhenotypicFeature">disease</info> is caused by <info type="SequenceVariant">large contiguous gene deletions</info> of the <info type="GeneOrGeneProduct">ALDH3A2</info> locus on <info type="GeneOrGeneProduct">17p11.2</info>. The <info type="SequenceVariant">deletions</info> were defined using <info type="ChemicalEntity">long distance inverse PCR</info> and <info type="ChemicalEntity">microarray-based comparative genomic hybridization</info>. A <info type="OrganismTaxon">24-year-old</info> <info type="OrganismTaxon">SLS</info> female was homozygous for a <info type="SequenceVariant">352-kb deletion</info> involving <info type="GeneOrGeneProduct">ALDH3A2</info> and <info type="SequenceVariant">4 contiguous genes</info> including <info type="GeneOrGeneProduct">ALDH3A1</info>, which codes for the major soluble <info type="GeneOrGeneProduct">protein</info> in <info type="OrganismTaxon">cornea</info>. Although lacking <info type="DiseaseOrPhenotypicFeature">corneal disease</info>, she showed severe symptoms of <info type="DiseaseOrPhenotypicFeature">SLS</info> with uncommon deterioration in <info type="DiseaseOrPhenotypicFeature">oral motor function</info> and <info type="DiseaseOrPhenotypicFeature">loss of ambulation</info>. The other <info type="OrganismTaxon">19-month-old</info> <info type="OrganismTaxon">female</info> patient was a <info type="SequenceVariant">compound heterozygote</info> for a <info type="SequenceVariant">1.44-Mb contiguous gene deletion</info> and a <info type="SequenceVariant">missense mutation</info> (<info type="SequenceVariant">c.407C&gt;T</info>, <info type="SequenceVariant">P136L</info>) in <info type="GeneOrGeneProduct">ALDH3A2</info>. These studies suggest that <info type="SequenceVariant">large gene deletions</info> may account for up to <info type="ChemicalEntity">5%</info> of the mutant alleles in <info type="DiseaseOrPhenotypicFeature">SLS</info>. <info type="GeneOrGeneProduct">Geneticists</info> should consider the possibility of <info type="SequenceVariant">compound heterozygosity</info> for <info type="SequenceVariant">large deletions</info> in patients with <info type="DiseaseOrPhenotypicFeature">SLS</info> and other <info type="DiseaseOrPhenotypicFeature">inborn errors of metabolism</info>, which has implications for <info type="DiseaseOrPhenotypicFeature">carrier testing</info> and <info type="DiseaseOrPhenotypicFeature">prenatal diagnosis</info>.